your ccure api by Lebsa and Selectchemie CAS-RN: 1257044-40-8
Venetoclax is a BH3 mimetic used to treat chronic lymphocytic leukemia. It blocks the anti-apoptotic B-cell lymphoma-2 (Bcl-2) protein.
Venetoclax is an integral CCURE solution that comes with a supply chain strategy and strong client support. It offers you a single RoS for all your markets, with four very efficient GMP Chemical steps completed at LEBSA in Barcelona.
RoS for all your markets, with four very efficient GMP chemical steps done in Barcelona.
suppliers of starting materials in order to reduce costs and risks.
Kg batch size. Ability to scale-up supplies in-house, if demand increases.
experienced internal QA, RA, IP and R&D teams to support your needs.
in DMF for non-EU countries such USA or Brazil.
Venetoclax offers a single RoS for all your markets, with the guarantee of an EUGMP validated by a large number of multinationals and the main international health authorities.
Our ASMF is customized per country and we have experience registering APIs with the main regulatory bodies (EMA, ANVISA, TGA, PMDA, MIT Russia, Taiwan FDA, China NMPA, Canada Health, etc.)
A logistics strategy to suit your needs